Cyclosporine-Associated Thrombotic Microangiopathy during Daclizumab Induction: A Suggested Therapeutic Approach

Hernán Trimarchi,Emilio Freixas,Oscar Rabinovich,J. Schropp,H. Pereyra,E. Bullorsky

Cyclosporine-Associated Thrombotic Microangiopathy during Daclizumab Induction: A Suggested Therapeutic Approach

2001

Hernán Trimarchi
Emilio Freixas
Oscar Rabinovich
J. Schropp
H. Pereyra
E. Bullorsky

A woman on daclizumab developed thrombotic microangiopathy secondary to cyclosporine after a living-unrelated kidney transplant. Despite cyclosporine discontinuation, hemolysis persisted. The second d

Keywords:

Discontinuation
Kidney transplantation
Gastroenterology
Ciclosporin
Internal medicine
Panel reactive antibody
Endocrinology
Daclizumab
Thrombotic microangiopathy
Immunology
Plasmapheresis
Tacrolimus
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations